Literature DB >> 18508848

Predictors for peripheral and carotid revascularization in a population-based cohort with type 2 diabetes.

Marijan Bosevski1, Vladimir Borozanov, Slavco Tosev, Irena Peovska, Snezana Meskovska-Bongard, Ljubica Georgievska-Ismail.   

Abstract

The study was aimed to define the predictors for peripheral and carotid revascularization in type 2 diabetic population. In all, 279 patients with type 2 diabetes and peripheral arterial disease were enrolled in a cohort longitudinal study. Study population was followed up for 24 months for the need and performance of peripheral or carotid revascularization. Logistic regression analysis was conducted to identify variables predictive of revascularization, when lipid plasma levels, glycemia, arterial hypertension, blood pressures, ankle-brachial index, intima-media thickness, body mass index, waist circumference, and hip distances were put in a model. Total cholesterol and maximal value of carotid intima-media thickness were presented as factors that independently influenced the performed peripheral revascularization. Waist circumference is defined as independent factor associated with carotid endarterectomy. Measurement of carotid intima-media thickness, waist circumference, and plasma lipid levels in type 2 diabetes with manifested peripheral and carotid arterial disease should be recommended in a manner of proper risk stratification of this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508848     DOI: 10.1177/0003319708317334

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  1 in total

1.  Color Doppler Ultrasonography Is a Useful Tool for Diagnosis of Peripheral Artery Disease in Type 2 Diabetes Mellitus Patients with Ankle-Brachial Index 0.91 to 1.40.

Authors:  Kyu Yeon Hur; Ji Eun Jun; Young Ju Choi; Yong Ho Lee; Dae Jung Kim; Seok Won Park; Byung Wook Huh; Eun Jig Lee; Sun Ha Jee; Kap Bum Huh; Sung Hee Choi
Journal:  Diabetes Metab J       Date:  2018-02       Impact factor: 5.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.